Boehringer Ingelheim

Boehringer Ingelheim (pronunciation: Bör-ing-er Ing-uh-lahym) is a global, research-driven pharmaceutical corporation based in Ingelheim am Rhein, Germany.

Etymology

The name "Boehringer Ingelheim" is derived from the surname of its founder, Albert Boehringer, and the town of its origin, Ingelheim am Rhein.

History

Boehringer Ingelheim was founded in 1885 by Albert Boehringer. Initially, the company produced lactic acid for use in the food industry, but it quickly expanded into the pharmaceutical sector. Today, Boehringer Ingelheim is one of the world's 20 leading pharmaceutical companies.

Products and Services

Boehringer Ingelheim's main areas of interest are respiratory diseases, cardiovascular diseases, oncology, neurological disorders, and immunology. The company is known for its innovative and high-quality products, including Pradaxa, Spiriva, and Jardiance.

Research and Development

Boehringer Ingelheim is committed to researching and developing new treatments for diseases with high unmet medical need. The company invests approximately 20% of its net sales in R&D.

Related Terms

External links

Medical encyclopedia article on Boehringer Ingelheim
Wikipedia's article - Boehringer Ingelheim

This WikiMD dictionary article is a stub. You can help make it a full article.

Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski

Boehringer Ingelheim